A Study of Arzoxifene to Treat Korean Women With Osteoporosis
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The study is for Korean women who are postmenopausal and also suffer from osteoporosis.
The study will test if women who are given 20 mg of arzoxifene once a day for six months have
a less severe level of osteoporosis than those women who do not take arzoxifene.
All patients will receive 500 mg of elemental calcium and 400 to 600 IU Vitamin D daily
starting 4 weeks prior to study drug administration continuing through the 6 months of
therapy.